Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Bottomley, J.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Economic costs of diabetes in the US in 2007 — Implications for Europe

Julia Bottomley

Bottomley Amygdala Ltd, The Warren, Willian Road, Letchworth Garden City, Hertfordshire, SG6 2AA, UK, jmb{at}amygdala.uk.com

In March 2008 the latest American Diabetes Association (ADA) commissioned economic study of the costs of diabetes in 2007 was published. The economic burden of diabetes was quantified in terms of its increased healthcare resource use (direct costs) and lost productivity (indirect costs) and provided a detailed breakdown of the costs attributed to diabetes. In the five years since the ADA published a similar analysis, the number of Americans with diagnosed diabetes has risen from 12.1 to 17.1 million and the economic cost has risen from $132 billion (equivalent to $153 billion in 2007 dollars) to $174 billion. This major analysis is reviewed and the implications for Europe are considered. The findings are similar to those described in earlier US studies and also landmark European economic studies in diabetes. The results are also discussed in the context of the well accepted association of type 2 diabetes and overweight and obesity and because obesity has reached epidemic proportions in developed and developing countries

Key Words: cost-effectiveness • cost of illness • guidelines obesity • type 2 diabetes.

The British Journal of Diabetes & Vascular Disease, Vol. 8, No. 2, 96-100 (2008)
DOI: 10.1177/14746514080080020801
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?